Novel MASP-2 inhibitors developed via directed evolution of human TFPI1 are potent lectin pathway inhibitors.

MASP-2 complement system complement-targeted therapy directed evolution innate immunity ischemia ischemia-reperfusion injury lectin pathway phage display protease inhibitor serine protease serine proteinase

Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
17 05 2019
Historique:
received: 06 03 2019
revised: 28 03 2019
pubmed: 7 4 2019
medline: 18 12 2019
entrez: 7 4 2019
Statut: ppublish

Résumé

The lectin pathway (LP) of the complement system is an important antimicrobial defense mechanism, but it also contributes significantly to ischemia reperfusion injury (IRI) associated with myocardial infarct, stroke, and several other clinical conditions. Mannan-binding lectin-associated serine proteinase 2 (MASP-2) is essential for LP activation, and therefore, it is a potential drug target. We have previously developed the first two generations of MASP-2 inhibitors by

Identifiants

pubmed: 30952698
pii: S0021-9258(20)36375-4
doi: 10.1074/jbc.RA119.008315
pmc: PMC6527154
pii:
doi:

Substances chimiques

Lipoproteins 0
Peptides 0
Serine Proteinase Inhibitors 0
lipoprotein-associated coagulation inhibitor 0
ecallantide 5Q6TZN2HNM
MASP2 protein, human EC 3.4.21.-
Mannose-Binding Protein-Associated Serine Proteases EC 3.4.21.-
Masp2 protein, rat EC 3.4.21.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8227-8237

Informations de copyright

© 2019 Szakács et al.

Références

J Immunol. 2009 Sep 1;183(5):3409-16
pubmed: 19667088
Nat Rev Nephrol. 2018 Jan;14(1):26-47
pubmed: 29199277
J Immunol. 2010 Oct 1;185(7):4169-78
pubmed: 20817870
J Neuroinflammation. 2016 Aug 30;13(1):213
pubmed: 27577570
Expert Opin Drug Metab Toxicol. 2008 Jul;4(7):871-7
pubmed: 18624676
Nature. 1989 Apr 6;338(6215):518-20
pubmed: 2927510
J Clin Microbiol. 2010 Mar;48(3):908-14
pubmed: 20042630
Sci Rep. 2016 Aug 18;6:31877
pubmed: 27535802
Proc Natl Acad Sci U S A. 1985 Jan;82(2):488-92
pubmed: 3881765
Nat Rev Drug Discov. 2010 Mar;9(3):189-90
pubmed: 20190785
Int J Cardiol. 2013 Jun 20;166(2):499-504
pubmed: 22178059
Semin Thromb Hemost. 2010 Sep;36(6):641-52
pubmed: 20865641
Front Immunol. 2015 May 26;6:257
pubmed: 26074922
J Immunol Methods. 2001 Nov 1;257(1-2):107-16
pubmed: 11687244
Clin Exp Immunol. 2012 Jul;169(1):38-48
pubmed: 22670777
Nat Rev Immunol. 2009 Oct;9(10):729-40
pubmed: 19730437
Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):10498-503
pubmed: 22691502
Nat Chem Biol. 2016 Dec;12(12):1105-1110
pubmed: 27775713
PLoS One. 2011;6(5):e20036
pubmed: 21625439
Blood. 1991 Jul 15;78(2):387-93
pubmed: 2070076
Autoimmun Rev. 2013 Jul;12(9):904-11
pubmed: 23537510
Immunobiology. 2018 Aug - Sep;223(8-9):519-523
pubmed: 29525356
J Biol Chem. 2011 Jun 24;286(25):22535-45
pubmed: 21515688
Adv Immunol. 2017;135:53-79
pubmed: 28826529
Circulation. 2012 Oct 30;126(18):2227-35
pubmed: 23032324
Science. 2016 May 6;352(6286):712-716
pubmed: 27033548
Int Immunol. 2007 Feb;19(2):141-9
pubmed: 17182967
Front Immunol. 2018 May 25;9:1151
pubmed: 29910807
J Immunol. 2009 Jul 15;183(2):1207-14
pubmed: 19564340
Front Immunol. 2015 Jun 02;6:262
pubmed: 26082779
Nat Chem. 2009 Jun;1(3):187-92
pubmed: 21378847
J Immunol. 2005 May 15;174(10):6373-80
pubmed: 15879138
J Immunol Methods. 2005 Jan;296(1-2):187-98
pubmed: 15680163
PLoS One. 2011;6(6):e21338
pubmed: 21712986
Immunol Rev. 2016 Nov;274(1):74-97
pubmed: 27782323
Eur J Immunol. 2015 Feb;45(2):544-50
pubmed: 25359215
PLoS One. 2010 Nov 10;5(11):e15443
pubmed: 21085669
Open Heart. 2018 Jan 9;5(1):e000652
pubmed: 29344374
Am J Pathol. 2015 Feb;185(2):347-55
pubmed: 25482922
Hum Genomics. 2016 Jun 21;10(1):23
pubmed: 27329102
Clin Med Insights Cardiol. 2011;5:49-54
pubmed: 21695090
Genome Res. 2004 Jun;14(6):1188-90
pubmed: 15173120
J Biol Chem. 2006 Aug 4;281(31):22378-85
pubmed: 16762925
Immunol Lett. 2010 Jul 8;131(2):139-50
pubmed: 20381531
Biochemistry. 1990 Aug 21;29(33):7539-46
pubmed: 2271516
Mol Immunol. 2004 Feb;40(13):921-9
pubmed: 14725788
Semin Immunopathol. 2018 Jan;40(1):15-35
pubmed: 29167939
Mol Immunol. 2013 Jul;54(3-4):408-14
pubmed: 23399387
Front Immunol. 2018 Aug 08;9:1851
pubmed: 30135690
J Immunol. 2018 Apr 1;200(7):2247-2252
pubmed: 29475986
Protein Pept Lett. 2005 Jul;12(5):465-71
pubmed: 16029159
J Mol Biol. 2019 Feb 1;431(3):557-575
pubmed: 30543823
Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):8950-4
pubmed: 10908667
J Mol Biol. 1997 Jun 13;269(3):395-407
pubmed: 9199408
Proc Natl Acad Sci U S A. 2011 May 3;108(18):7523-8
pubmed: 21502512
FASEB J. 2014 Sep;28(9):3996-4003
pubmed: 24868011
Biochimie. 2010 Nov;92(11):1689-704
pubmed: 20470858
PLoS One. 2018 Jan 11;13(1):e0191292
pubmed: 29324883
J Immunol. 2003 Feb 1;170(3):1374-82
pubmed: 12538697
Biochemistry. 1997 Feb 18;36(7):1598-607
pubmed: 9048543
Nat Immunol. 2010 Sep;11(9):785-97
pubmed: 20720586
Immunobiology. 2007;212(4-5):267-77
pubmed: 17544812
J Biol Chem. 2012 Jun 8;287(24):20290-300
pubmed: 22511776
Biochem Biophys Res Commun. 1967 Apr 20;27(2):157-62
pubmed: 6035483
J Immunol. 2016 Jan 15;196(2):857-65
pubmed: 26673137
Int J Toxicol. 2009 May-Jun;28(3):230-53
pubmed: 19546261
J Med Chem. 2018 Jul 26;61(14):6153-6162
pubmed: 29920096

Auteurs

Dávid Szakács (D)

Department of Biochemistry, ELTE Eötvös Loránd University, Pázmány Péter sétány 1/C, H-1117 Budapest.

Andrea Kocsis (A)

Institute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Magyar tudósok körútja 2, H-1117 Budapest.

Róbert Szász (R)

Department of Hematology, Institute of Internal Medicine, University of Debrecen, Nagyerdei krt. 98, H-4032 Debrecen.

Péter Gál (P)

Institute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Magyar tudósok körútja 2, H-1117 Budapest.

Gábor Pál (G)

Department of Biochemistry, ELTE Eötvös Loránd University, Pázmány Péter sétány 1/C, H-1117 Budapest; EvolVeritas Biotechnology Ltd., Somogyi Béla u. 17, H-6600 Szentes, Hungary. Electronic address: gabor.pal@ttk.elte.hu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH